Schedules to Response Biomedical Corp. Securities Purchase Agreement dated as of March 30, 2006 SCHEDULE 3.1(a) SUBSIDIARIES.Response Biomedical Corp • April 4th, 2006 • Services-testing laboratories
The Company has agreed to pay Dr. Anthony Holler and Mr. Todd Patrick $40,000 each as consideration for joining the board of directors of the Company and assisting with the board reorganization. Dr. Holler and Mr. Patrick have agreed to accept this payment in the form of common shares of the Company, issued at a deemed price of $0.60 per share. Accordingly, the Company will issue an aggregate of 133,332 common shares of the Company to Dr. Holler and Mr. Patrick upon closing of the Financing.
RESPONSE BIOMEDICAL CORP. SUBSCRIPTION FOR UNITSResponse Biomedical Corp • April 4th, 2006 • Services-testing laboratories
The undersigned (the “Subscriber”) hereby subscribes for and agrees to purchase the number of units (the “Units”) in the capital of the Company, set forth below for the aggregate subscription price set forth below, representing a subscription price of C$0.50 per Unit (which, in the case of a Subscriber that prefers to subscribe in United States dollars, shall be deemed to equal US$0.4332756), upon and subject to the terms and conditions set forth in the “Terms and Conditions of Subscription for Securities of Response Biomedical Corp.” attached to and forming a part hereof. Each Unit is comprised of (i) one common share of the Company (“Common Share”), and (ii) one-half (1/2) of a common share purchase warrant (the “Warrants”), each whole Warrant entitling the Subscriber to purchase one additional Common Share (a “Warrant Share”) for a period of two years from the Closing Date (as defined herein) at a subscription price of C$0.62 per Warrant Share (subject to customary adjustments). Thi
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 4th, 2006 • Response Biomedical Corp • Services-testing laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March “30”, 2006, among Response Biomedical Corp., a British Columbia corporation (the “Company”), and each Purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”); and
RESPONSE BIOMEDICAL CORP. SUBSCRIPTION FOR UNITSResponse Biomedical Corp • April 4th, 2006 • Services-testing laboratories
The undersigned (the “Subscriber”) hereby irrevocably subscribes for and agrees to purchase the number of units (the “Units”) in the capital of the Company, set forth below for the aggregate subscription price set forth below, representing a subscription price of C$0.50 per Unit upon and subject to the terms and conditions set forth in the “Terms and Conditions of Subscription for Securities of Response Biomedical Corp.” attached to and forming a part hereof. Each Unit is comprised of (i) one common share of the Company (“Common Share”), and (ii) one-half (1/2) of a common share purchase warrant (“W arrant”), each whole Warrant entitling the Subscriber to purchase one additional Common Share (a “Warrant Share”) for a period of two years from the Closing Date (as defined herein) at a subscription price of C$0.62 per Warrant Share (subject to customary adjustments). This subscription is subject to acceptance by the Company and may be accepted as to the number of Units set forth below or
